Venus Medtech (启明医疗) Pre-IPO: Thoughts on Valuation
Venus Medtech (Hangzhou) is a dominant player in the heart valve replacement devices market in China. The company started pre-marketing for a USD...
527 Views
Venus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers
Venus Medtech, a China Hangzhou-based transcatheter heart valve medical device player, is looking to raise up to USD 300 million via a listing in...
680 Views
Venus Medtech IPO Initiation: The Heart of the Business
Venus MedTech Hangzhou Inc (1392140D CH) is a leading transcatheter heart valve medical device company in China. VenusA-Valve, a self-developed...
750 Views
U.S. Dollar Breaking Down; Gold Breaking Out
The S&P 500 is consolidating under 2,954 - logical resistance - as market participants are in wait-and-see mode for incremental trade news...
412 Views
U.S. Equity Strategy: Defensive Areas Weakening; Broad Market Attempting to Bottom
In this report we detail our U.S. investment thesis and provide a detailed technical appraisal of the broad market, as well as highlighting...
600 Views